Product
AHCT intensification
Aliases
melphalan, darzalex, revlimid
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
MRD-Guided Sequential Therapy For Deep Response in Newly Diagnosed Multiple Myeloma - MASTER-2 TrialStatus: Recruiting, Estimated PCD: 2026-12-01